Summary: The mean serum calcium of 13 hyperthyroid patients was found to be significantly higher than that of controls matched for sex and age, though none of the patients' values were outside the normal range. Nevertheless, these patients responded very promptly to hypercalkaemia (induced by an intravenous calcium load), and their serum calcium returned to normal much more rapidly compared with the matched controls. There was also increased retention of intravenous calcium load, possibly owing to increased calcitonin production. Calcium infusion may be useful in treating bone diseases in which increased bone resorption exceeds bone accretion.
Introduction
Hypercalcaemia in hyperthyroidism not associated with hyperparathyroidism, though rare, has been reported (Epstein et al. 1958; Kleeman et al., 1958) . Adams et al. (1967) found the mean serum calcium of hyperthyroid patients to be higher (P<OO1) than that of a group of normal subjects matched for sex and age, and since the mean serum albumin conicentration of these patients was less (P<O0OO1) than that of the normal subjects these workers deduced that the serum concentration of the biologically important ionized calcium in hyperthyroid patients was greater than normal. This was confirmed by Frizel et al. (1967) , who directly measured serum ionized calcium in hyperthyroid patients.
In view of the established presence of hypercalcaemia in hyperthyroidism we have undertaken a study of the homoeostat~ic control of plasma calcium in this condition. Adams et al. (1967) have studied the response to induced hypocalcaemia, In the present investigation the response to induced hypercalcaemia is investigated.
Materials and Methods
(1) In 13 patients (seven males, six females) with untreated hyperthyroidism established clinically and by radioactive iodine uptake, changes in serum calcium were studied following an infusion of calcium. The patients were aged from 16 to 58 years and had no evidence of any concomitant illness. They were matched for sex and age with 13 normal controls.
Patients (2) In another group of six untreated hyperthyroid patients and six normal controls a test of calcium retention was carried out. Patients were put on a low (150 mg.) calcium diet for four days, and urine was collected daily for estimation of Hyperthyroid 24-hour urinary excretion of calcium. On the fourth day an infusion of calcium gluconate (15 mg. of calcium/kg. body weight) was given over four hours. The amount retained, expressed as percentage of infused load, is calculated by subtracting from the infused load (L) the difference between the 24-hour urinary calcium excretion (A) of the day of infusion and that (B) of the previous day-that is, L-'A-B).
Results
The patients' mean preinfusion serum calcium, 9 72 (±S.E. of mean 0-16) mg./100 ml., is significantly higher ( P<0 01) than that of their matched controls, 919 ( S.E. of mean 0-12) mg./ 100 ml. (Fig. 1 ). Yet at the fourth hour, when the highest serum calcium occurs, the patients' mean serum calcium, 11 9 (+S.E. of mean 013) mg./100 ml., is actually lower (0-001< P<001) than that of the controls, 12 9 (-S.E. of mean 0 26 The difference in the response to intravenous calcium-loading between the two groups is clearly brought out by computing the calcium tolerance area (Fig. 2) . Hyperthyroid patients have significantly smaller (P<0 001) areas than their matched controls, the mean for the patients being 3 4 ( S.E. of mean 046) units arid that for the controls 8 7 (+S.E. of mean 0-54) units. (Foster, 1968) . Hypercalcaemia arising from hyperthyroidism (Frizel et al., 1967) would be expected to suppress the parathyroid glands and to stimulate the calcitonin-producing apparatus. Suppression of the parathyroid has been indirectly shown (1967) found that the hypocalcaemic effect of calcitonin on plasma calcium is positively related to the prevailing rate of bone turnover. This is understandable, as calcitonin acts primarily by inhibiting bone resorption (Aliapoulios et al., 1966) . In the presence of calcitonininhibited bone resorption the prevailing increased bone accretion rate would lower plasma calcium more rapidly and to a greater extent than if the accretion rate was normal or subnormal. The work of Krane et al. (1956) and Eisenberg and Gordan (1961) (Osterberg and Mills, 1932; Jowsey, 1966; Adams et al., 1967) . This is supported by results of tracer studies by Krane et al. (1956) and Eisenberg and Gordan (1961) .
The results of this study suggest that in bone disease in which increased bone resorption exceeds increased bone accretion, such as hyperthyroid osteoporosis (Krane et al., 1956; Eisenberg and Gordan, 1961; Jowsey, 1966; Adams and Jowsey, 1967 ), Paget's disease (Nagant de Deuxchaisnes and Krane, 1964; Jowsey, 1966) , and acromegaly (Eisenberg and Gordan, 1961) , calcium infusion might be a useful therapeutic measure. By indirectly inhibiting the prevailing increased bone resorption in the presence of increased bone accretion, calcium infusion greatly enhances net bone accretion as our results suggest, and may lead to healing of bone itself. Moreover, hypercalcaemia induced by calcium infusion in these circumstances, as shown by our results, is relatively mild and shortlived-a decided advantage. This would not be so if bone accretion rate is normal in the presence of increased bone resorption as in postmenopausal and senile osteoporosis (Lafferty et al., 1964) , in which hypercalcaemia would be expected to be as prolonged as in the normal. If shown to be effective and safe, calcium infusion would present a significant advance in the treatment of those bone diseases in which kinetic studies indicate high turnover rate with increased bone resorption exceeding increased bone accretion.
